DRAXIS and Isotope Products Laboratories Sign Distribution AgreementDraxis Health Inc /Cn/ • March 23rd, 2004 • Pharmaceutical preparations
Mississauga, Ontario, March 22, 2004—DRAXIMAGE Inc., the radiopharmaceutical subsidiary of DRAXIS Health Inc. (TSX: DAX, Nasdaq: DRAX), has concluded a distribution agreement with Isotope Products Laboratories (IPL), a California based producer of radioactive sources for Nuclear Medicine and radiography. DRAXIMAGE will market the full line of IPL medical products in Canada, including calibration references for imaging applications plus calibration sources for PET (Positron Emission Tomography) and SPET (Single Photon Emission Tomography), all well-established modes of diagnostic medical imaging. DRAXIMAGE will also introduce the Perflexion™, IPL's new flexible Cobalt-57 flood source, in Canada during the second quarter of 2004.
